Molecular approaches to epidemiology and clinical aspects of malaria.
Malaria is a problem of global importance, responsible for 1-2 million deaths per year, mainly in African children, as well as considerable morbidity manifested as severe anaemia and encephalopathy in young children. Fundamental to the development of new tools for malaria control in humans is an increased understanding of key features of malaria infection, such as the diversity of outcome in different individuals, the understanding of different manifestations of the disease and of the mechanisms of immunity that allow clinical protection in the face of ongoing low-grade infection (concomitant immunity or premunition). Here, Graham Brown and colleagues review some of the ways in which molecular approaches might be used to increase our understanding of the epidemiology and clinical manifestations of malaria, as discussed at the Molecular Approaches to Malaria conference (MAM2000), Lorne, Australia, 2-5 February 2000.
Brown
G V
GV
Department of Medicine, University of Melbourne, Australia. g.brown@medicine.unimelb.edu.au
Beck
H P
HP
Molyneux
M
M
Marsh
K
K
D000818:Animals; D002648:Child; D006801:Humans; D017780:Malaria Vaccines; D016778:Malaria, Falciparum / Q000453:epidemiology* / Q000276:immunology / Q000469:parasitology / Q000503:physiopathology*; D010963:Plasmodium falciparum / Q000235:genetics / Q000276:immunology*
D017780:Malaria Vaccines